We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Supportive Therapy for Adherence to ART(STAART)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00212940
Recruitment Status : Completed
First Posted : September 21, 2005
Last Update Posted : July 26, 2007
Information provided by:

Study Description
Brief Summary:
The purpose of this study is to determine whether a psycho-educational intervention can help people living with HIV handle the changes of treatment adherence.

Condition or disease Intervention/treatment
HIV Infections Behavioral: Supportive Therapy for Adherence to ART (behavior)

Detailed Description:

Participants will be randomly assigned to one of two study groups:

  • Group 1: participants in this group will engage in weekly psycho-educational sessions with an HIV therapist for four weeks prior to starting their regimens. The sessions will cover topics such as becoming active in treatment care, improving coping abilities and developing skills for treatment adherence. They will also involve questionnaires and readings.
  • Group 2 (the control group):participants in this group will simply receive their regular treatment regimens.

Study Design

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 112 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Official Title: Increasing Patient Adherence to HIV Medications: A Prospective Intervention Study
Study Start Date : October 2000
Study Completion Date : September 2006

Resource links provided by the National Library of Medicine

MedlinePlus related topics: HIV/AIDS
U.S. FDA Resources

Arms and Interventions

Outcome Measures

Primary Outcome Measures :
  1. psycho-educational intervention can help people living with HIV handle the changes of treatment adherence

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • be at least 18 years of age
  • have viral load above 500 copies/ml
  • not be currently on HAART
  • be able to read and speak English/French

Exclusion Criteria:

  • current Substance Abuse
  • actively psychotic or suicidal
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00212940

Canada, Ontario
The Ottawa Hospital, General Campus
Ottawa, Ontario, Canada, K1H 8L6
Sponsors and Collaborators
Ottawa Hospital Research Institute
Ontario HIV Treatment Network
Principal Investigator: William Cameron, MD OHRI
More Information

ClinicalTrials.gov Identifier: NCT00212940     History of Changes
Other Study ID Numbers: 1999565-01H
CIHR app# 1262000 ICE:
First Posted: September 21, 2005    Key Record Dates
Last Update Posted: July 26, 2007
Last Verified: July 2007

Keywords provided by Ottawa Hospital Research Institute:
Treatment Naive

Additional relevant MeSH terms:
HIV Infections
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Virus Diseases
Sexually Transmitted Diseases, Viral
Sexually Transmitted Diseases
Immunologic Deficiency Syndromes
Immune System Diseases